Physician profile
Gary V Wertman
NPI 1083805006
$877.85
in general payments reported to CMS, 2019-2025
15 companies · $14.84 in 2025
The $14.84 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38.43 · 2020: $51.93 · 2021: $49.83 · 2022: $430 · 2023: $162 · 2024: $131 · 2025: $14.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $308.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $307.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $397.68 | 2022 | |
| Axogen | $97.07 | 2024 | Axoguard Nerve Cap, Axoguard Ha+ Nerve Protector, Axoguard Nerve Protector |
| Orthofix Medical, INC. | $92.60 | 2019-2023 | Physio-Stim |
| Smith+Nephew, INC. | $49.83 | 2021 | |
| Stryker Corporation | $33.85 | 2023 | Gamma |
| Endo USA, INC. | $33.67 | 2024 | Xiaflex |
| Kowa Pharmaceuticals America, INC. | $31.09 | 2023 | Seglentis |
| Heron Therapeutics, INC. | $23.75 | 2023 | Zynrelef |
| Fidia Pharma USA INC. | $21.25 | 2020 | |
| Endo Pharmaceuticals INC. | $19.16 | 2023 | Xiaflex |
| Baxter Healthcare | $17.35 | 2022 | |
| Zimmer Biomet Holdings, INC. | $15.82 | 2020 | |
| Avanos Medical | $15.03 | 2022 | |
| Glaxosmithkline, LLC. | $14.86 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $14.84 | 2025 | Zilretta, Iovera, Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Wertman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.